Louisiana 2016 Regular Session

Louisiana House Bill HB282

Introduced
3/2/16  
Introduced
3/2/16  
Refer
3/2/16  
Refer
3/2/16  
Refer
3/14/16  

Caption

Provides for a liberative prescriptive period of two years

Impact

The shift from a one-year to a two-year prescriptive period reflects an understanding of the complexities often involved in delictual actions, particularly those linked to violent crimes. Supporters of the bill argue that this change will better accommodate the needs of victims, allowing them more time to process their experiences and gather the necessary evidence for their cases. Furthermore, retaining the one-year prescriptive period for medical malpractice actions under R.S. 9:5628 acknowledges the unique nature of such claims, ensuring that patients still have a more expedited process to address grievances against medical professionals.

Summary

House Bill 282 proposes a significant alteration to Louisiana's laws regarding the prescriptive periods for delictual actions, which are civil actions that arise from wrongful acts that cause harm. The primary objective of this bill is to extend the liberative prescriptive period for these types of actions from the current one-year limit to a new two-year limit. This change aims to provide individuals with additional time to seek legal recourse for damages they may have suffered due to actions defined as crimes of violence under state law. The amendment to Civil Code Article 3493.10 is a pivotal aspect of this legislation, as it directly impacts how quickly individuals must act to pursue their claims in court.

Sentiment

The sentiment surrounding HB 282 appears to be generally supportive among advocates for victims' rights and those who emphasize the importance of providing adequate time frames for bringing forth claims. However, there may also exist concerns regarding the implications of such changes on defendants and the potential for increased litigation as claimants have a broader window to file their lawsuits. The legal community's response has been mixed, indicating a balance of perspectives on the bill's potential outcomes.

Contention

Despite the bill's supportive reception, some points of contention may arise regarding how the increase in the prescriptive period will affect the burden of proof within civil courts. Opponents could argue that lengthening the timeframe may complicate matters for defendants who may find it more challenging to mount their defenses as time passes. Additionally, the bill's contingent effective date, requiring the simultaneous passage of House Bill 89, introduces another layer of complexity and dependency that could spark debate among legislators regarding its overall implementation.

Companion Bills

No companion bills found.

Previously Filed As

LA HB552

Provides relative to liberative prescription

LA HB767

Extends the prescriptive period in tort actions from one year to two years

LA HB556

Provides a three-year liberative prescriptive period for actions arising from cases of rape

LA HB588

Provides relative to extending liberative prescriptive periods

LA SB241

Extends prescriptive period for delictual actions from one to two years, but except medical malpractice. (1/1/21)

LA HB92

Provides relative to the prescriptive period for delictual actions

LA SB2

Extends prescriptive period for certain delictual actions from one to two years. (1/1/21) (OR SEE FISC NOTE GF EX)

LA SB130

Provides for liberative prescription. (gov sig)

LA HB109

Provides relative to prescription of delictual actions

LA SB334

Provides relative to certain prescriptive periods for delictual actions. (8/1/24)

Similar Bills

CA AB2789

Health care practitioners: prescriptions: electronic data transmission.

CA AB852

Health care practitioners: electronic prescriptions.

CA AB149

Controlled substances: prescriptions.

TX HB2246

Relating to certain procedures applicable to electronic prescriptions for Schedule II controlled substances.

TX SB594

Relating to the regulation of prescriptions for controlled substances, including certain procedures applicable to electronic prescriptions for Schedule II controlled substances.

TX HB2766

Relating to electronic and other controlled substance prescriptions under the Texas Controlled Substances Act; authorizing a fee.